TransMedics Group's recent profit announcement disappointed investors despite strong headline numbers. The accrual ratio of 0.36 shows its profit is not backed by free cash flow, raising concerns about the company's financial health and future profitability. Analysts' forecasts and potential risks should be considered by investors.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay